NCT06192797
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Clinical trial condition
Cholangiocarcinoma Non-resectable
Explore clinical trials studying Cholangiocarcinoma Non-resectable. Study availability and eligibility vary by location and protocol.
13 public trials
5 recruiting studies
Cholangiocarcinoma Non-resectable trial results
NCT05655949
- Conditions
- Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +14 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT03364530
- Conditions
- Cholangiocarcinoma Non-resectable, Non-metastatic
- Locations
-
- Amiens University Hospital Amiens, France
- Angers University Hospital Angers, France
- Bordeaux University Hospital Bordeaux, France
- Centre Georges François Leclerc Dijon, France
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
- Locations
-
- Oslo University Hospital Oslo, Norway
NCT06487663
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
Not yet recruiting
TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort
NCT07454486
- Conditions
- Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), +28 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark
Not yet recruiting
Preoperative Right Hepatic Artery Embolization for Locally Advanced Bismuth IIIb and IV Perihilar Cholangiocarcinoma
NCT07326189
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
Not specified
Enrolling by invitation
Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction
NCT06671418
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Cholangiocarcinoma Non-resectable, +9 more
- Locations
-
- Erasmus MC Rotterdam, Netherlands
Active, not recruiting
A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation
NCT06081829
- Conditions
- Cholangiocarcinoma Metastatic, Cholangiocarcinoma Non-resectable
- Locations
-
- National Cancer Center Hospital East (JPN-002) Kashiwa, Japan
- Kumamoto University Hospital (JPN-004) Kumamoto, Japan
- National Hospital Organization Shikoku Cancer Center (JPN-007) Matsuyama, Japan
- Osaka International Cancer Institute (JPN-005) Osaka, Japan
NCT03377179
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +8 more
- Locations
-
- Mayo Clinic Cancer Center Phoenix, Arizona, United States
- Emory University Atlanta, Georgia, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
- MD Anderson Cancer Center Houston, Texas, United States